Leukotrienes C4 and D4 in psoriatic skin lesions.
Chemoattractant arachidonate lipoxygenase products have been recovered from the skin lesions of psoriasis, and may play a role in eliciting the intra-epidermal neutrophil infiltrate that characterises this disease. In view of evidence for lipoxygenase activity in psoriasis, the characteristic vasodilation in psoriatic lesions, and the vasodilator properties of leukotriene (LT) C4 and D4 in human skin, the presence of these LTs in psoriatic lesions has been investigated. Skin chamber fluid from abraded psoriatic lesions contained significantly greater amounts of immunoreactive material than that from clinically normal skin, as determined by a double antibody radioimmunoassay (RIA) that uses antiserum cross-reacting with both LTC4 and LTD4. Purification of lesional chamber fluid and scale extracts by high performance liquid chromatography (HPLC) and RIA of fractions showed immunoreactivity which co-eluted with standard LTC4 and LTD4. These findings suggest that LTC4 and LTD4 may play a role in mediating the vasodilation and increased blood flow that characterise psoriatic skin lesions.
Brain
S D
SD
Camp
R D
RD
Black
A K
AK
Dowd
P M
PM
Greaves
M W
MW
Ford-Hutchinson
A W
AW
Charleson
S
S
D000293:Adolescent; D000328:Adult; D000368:Aged; D006801:Humans; D007975:Leukotriene B4 / Q000378:metabolism; D008084:Lipoxygenase / Q000378:metabolism*; D008875:Middle Aged; D011565:Psoriasis / Q000378:metabolism*; D011863:Radioimmunoassay; D013189:SRS-A / Q000378:metabolism*; D012867:Skin / Q000378:metabolism
D013189:SRS-A; D007975:Leukotriene B4; D008084:Lipoxygenase